German Practice REGIONAL PRACTICES

Our firm recognized the growing political and economic significance of Berlin as the government seat of unified German early on, opening its offices in the capital in 1993 as one of the first US law firms. In 2002, the company merged with the renowned and longstanding Berlin firm, Quack Rechtsanwälte, in existence since 1954. In 2008, the firm expanded its German Practice with the opening of a new office in Frankfurt. We now have 60 resident attorneys and notaries in the two offices.

Our range of services spans the entire spectrum of corporate and business law and complements the crucial role Berlin plays as a hub of politics and business. Our location is a symbol of the tradition our firm has of providing advice where law, business and policy come together.

Our practices include:

  • Corporate Law (including corporate finance, M&A, private equity and venture capital)
  • Bank and Capital Market Law
  • Tax
  • Labor and Employment
  • Real Estate
  • Intellectual Property Law (IP)
  • Information Technology
  • Litigation and Dispute Resolution
  • International Arbitration
  • Antitrust and Competition, Merger Control
  • International Trade, Investment and Market Access
  • Public Commercial Law
  • Aviation
  • Energy
  • Telecommunications, Media and E-Commerce
  • Financial Services
  • Legal strategy and Public Policy

We focus on the aviation/tourism, energy and telecommunications industries. In addition, we represent both domestic and foreign companies in the fields of technology and media, transport and logistics, as well as banks and financial services providers.

Office Contacts

Martin Seyfarth Partner, Berlin+49 30 20 22 64 30 martin.seyfarth@wilmerhale.com

Reinhart LangePartner, Frankfurt+49 69 27 10 78 201reinhart.lange@wilmerhale.com

Brussels/EU Practice

We opened our office in Brussels in 1990, just as the European Community introduced its Merger Control Regulation and in anticipation of the impact of the single market. The expansion of our firm was an important strategic decision, and one taken at just the right time. Concentrating on complex, challenging issues at the intersection of business, law and policy, the office has gained widespread recognition as one of the premier law offices in Brussels.

The office’s practice focuses are:

  • International Trade, Investment and Market Access
  • Antitrust and Competition, Merger Control
  • Public Commercial Law
  • Legal Strategy and Public Policy
  • Corporate Law
  • Aviation
  • Telecommunications, Media and E-Commerce
  • International Arbitration

Our highly experienced team of lawyers is qualified in many of the major European and North American jurisdictions, including Germany, Belgium, France, Austria, Ireland, Italy, the Netherlands, the United Kingdom, the United States and Canada. Professor Claus-Dieter Ehlermann, resident in the Brussels office, perhaps best personifies these qualities. As former chairman of the Appellate Body of the World Trade Organization and Director-General of DG Competition of the European Commission, he is one of the leading experts in the field of EU, competition and trade law. This unparalleled experience with all key EU institutions, EU decision-making committees and bodies is one of the factors behind the international repute of our team.

Office Contacts

Christian Duvernoy Partner +32 2 285 49 06 christian.duvernoy@wilmerhale.com

Our firm recognized the growing political and economic significance of Berlin as the government seat of unified German early on, opening its offices in the capital in 1993 as one of the first US law firms. In 2002, the company merged with the renowned and longstanding Berlin firm, Quack Rechtsanwälte, in existence since 1954. In 2008, the firm expanded its German Practice with the opening of a new office in Frankfurt. We now have 60 resident attorneys and notaries in the two offices.

Our range of services spans the entire spectrum of corporate and business law and complements the crucial role Berlin plays as a hub of politics and business. Our location is a symbol of the tradition our firm has of providing advice where law, business and policy come together.

Read More

Leadership

Sort By
Seyfarth, Martin

Martin Seyfarth

Partner-in-Charge, Berlin Office

+49 30 20 22 64 30 (t)

martin.seyfarth@wilmerhale.com

Lange, Reinhart

Reinhart Lange

Partner-in-Charge, Frankfurt Office

+49 69 27 10 78 201 (t)

reinhart.lange@wilmerhale.com

Braun, Martin

Dr. Martin Braun

Partner

+49 69 27 10 78 207 (t)

martin.braun@wilmerhale.com

Crones, Christian

Dr. Christian Crones

Partner

+49 69 27 10 78 207 (t)

christian.crones@wilmerhale.com

Heithecker, Jan

Dr. Jan Heithecker

Partner

+49 30 20 22 63 32 (t)

jan.heithecker@wilmerhale.com

Lange, Reinhart

Reinhart Lange

Partner

+49 69 27 10 78 201 (t)

reinhart.lange@wilmerhale.com

Ohlhoff, Stefan

Dr. Stefan Ohlhoff

Partner

+49 30 20 22 63 55 (t)

stefan.ohlhoff@wilmerhale.com

Quack, Ulrich

Ulrich Quack

Partner

+49 30 20 22 63 32 (t)

ulrich.quack@wilmerhale.com

Publications & News

View

April 17, 2013

Selected 2013 Technology Transactions

For more than four decades, we have represented technology clients in venture capital financings, public offerings, and mergers and acquisitions; handled their licensing, outsourcing, services, joint venture, development and distribution transactions throughout the world; protected their innovations through patent prosecution and portfolio development; defended their interests in enterprise‑critical patent litigation; and navigated regulatory issues vital to their success.

April 17, 2013

Selected 2013 Strategic Alliances, Joint Venture and Licensing Transactions

In 2013, our corporate, licensing, intellectual property and regulatory lawyers handled numerous strategic alliance, joint venture, licensing, collaboration, product development, outsourcing, manufacturing, distribution and similar agreements, including many significant deals that are helping to shape the future of science and technology.

April 17, 2013

Selected 2013 Life Sciences Transactions

Recognized both globally and nationally as a leading life sciences practice, WilmerHale has four decades of experience representing biotechnology, pharmaceutical and medical device companies at all stages of growth, as well as venture capitalists and investment banks.

February 28, 2013

Holger Thomas, Tim Corbett Receive 2013 ILO Client Choice Awards

Frankfurt-based Corporate Partner Dr. Holger Thomas and London-based Corporate Partner Tim Corbett have received 2013 Client Choice awards from International Law Office (ILO) and were honored at a gala dinner held in London on February 27.

February 4, 2013

WilmerHale 2012 in Review

As another busy year gathers momentum, we are pleased to report to you on some of the firm’s key achievements of the past 12 months. In 2012, we were privileged to gain a fresh appreciation for the depth and breadth of our practices, the financial strength of our firm, and the loyalty of our remarkable clients, from our new vantage as co-managing partners. It was an exciting year, as our lawyers and staff responded with enthusiasm and dedication to the continued strong demand for our services, and our clients and friends showed their ongoing support in countless ways.

December 18, 2012

Intellectual Property Law in 2012

With another successful year in 2012, we are stepping back to consider some of the highlights in intellectual property law and our IP practice. The continued implementation of the America Invents Act has led to new thinking about patent strategy and the use of various post-grant proceedings. The courts and practitioners have continued to wrestle with the scope of patentable subject matter, direct and indirect infringement, inequitable conduct, damages, and other issues. At the same time, the intersection of IP and other areas of law continues to expand, such as with the scrutiny concerning the adequacy of disclosures of patent rights during standards-setting. Our IP practice has been active in these and other areas.

July 19, 2012

WilmerHale counsels PAION AG in licensing agreement with Yichang

June 25, 2012

WilmerHale Secures Major Deal for Nabriva Therapeutics and Forest Laboratories

June 6, 2012

Selected 2012 Technology Transactions

For more than four decades, we have represented technology clients in venture capital financings, public offerings, and mergers and acquisitions; handled their licensing, outsourcing, services, joint venture, development and distribution transactions throughout the world; protected their innovations through patent prosecution and portfolio development; defended their interests in enterprise‑critical patent litigation; and navigated regulatory issues vital to their success.

June 6, 2012

Selected 2012 Strategic Alliances, Joint Venture and Licensing Transactions

In 2012, our corporate, licensing, intellectual property and regulatory lawyers handled numerous strategic alliance, joint venture, licensing, collaboration, product development, outsourcing, manufacturing, distribution and similar agreements, including many significant deals that are helping to shape the future of science and technology.

Events

June 14, 2013

GCR Live IP & Antitrust

Brussels, Belgium

March 19, 2013

Federal Assembly

Wiesbaden, Germany

March 12, 2013

Law and Economics of the WTO: Dispute Settlement

Florence, Italy

February 26, 2013

Regulation on Medical Devices(MDs) and In Vitro Diagnostic Medical Devices (IVDMDs)

Brussels, Belgium

January 29, 2013

C5 European Forum on Anti-Corruption in Frankfurt

Frankfurt, Germany

June 28-29, 2012

Annual Conference on Business Evaluation

Mainz, Germany

June 8, 2012

Management Forum: Clinical Trial Seminar

London, UK

April 23-24, 2012

C5's Global Investigations Europe

Berlin, Germany

March 29, 2012

Anti-Corruption & Compliance Summit 2012

Frankfurt, Germany

March 28-30, 2012

60th ABA Section of Antitrust Law Spring Meeting

Washington, DC